Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
LUXA was delisted on the 28th of October, 2022.
7 hedge funds and large institutions have $54.7M invested in Lux Health Tech Acquisition Corp. Class A Common Stock in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$26.2M |
| 2 |
RIA
RP Investment Advisors
Toronto,
Ontario, Canada
|
+$10M |
| 3 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$7.62M |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$4.6M |
| 5 |
SC
Sculptor Capital
New York
|
+$3.21M |
Top Sellers
LUXA Hedge Fund Activity: Q4 2020 in Review
7 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q4 2020, worth a combined $54.7M.
Buyers outnumbered sellers: 7 funds opened new LUXA positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $26.2M.
- 7 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $54.7M of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q4 2020.
- 7 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q4 2020 and 0 closed out, a net change of +7 holders.
- The largest Lux Health Tech Acquisition Corp. Class A Common Stock buyer in Q4 2020 was Millennium Management, an estimated $26.2M added.
Based on aggregated 13F filings for Q4 2020.